Newsroom
February 8, 2008
With an estimated 1 in 6 American men being diagnosed with prostate cancer at some point in their lives and only 1 in 35 estimated to die of the disease*, some researchers are questioning how many of those men are receiving treatment and impairing their quality of life unnecessarily.
September 21, 2007
Age adjustment, a method used by physicians to evaluate prostate-specific antigen (PSA) levels and cancer risk in men according to age, may be hindering the early detection of prostate cancer in older men, according to a study released Sept. 14 in the Journal of Urology.
May 16, 2007
A natural, over-the-counter herbal supplement on the market to help joint inflammation also shows robust ability to curb prostate cancer, according to a rodent study described by researchers from The University of Texas Health Science Center at San Antonio.
August 22, 2006
The medication finasteride, which after the seven-year Prostate Cancer Prevention Trial (PCPT) was associated with a 24.8 percent reduction of prostate cancer risk among men who took it, has a new feather in its cap – it beefs up the diagnostic power of the prostate-specific antigen (PSA) test.
August 8, 2006
An over-the counter herbal supplement derived from the Amur cork tree (Phellodendron amurense) killed a high percentage of cultured prostate cancer cells in studies conducted at The University of Texas Health Science Center at San Antonio.
April 26, 2006
Within moments at a computer, a man 55 or older who is concerned about his chance of developing prostate cancer can obtain a trustworthy, science-based estimate of risk – information that can help him decide whether or not to see a physician.